ANDREW SIROIS: Open Payments
NPI 1396521829 · PLEASANT PRAIRIE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 36 payments from 11 companies in 2025. Trend: 2023 $73 · 2024 $945 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $188 |
| AstraZeneca Pharmaceuticals LP | 7 | $116 |
| HEARTFLOW, INC. | 5 | $110 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| Merck Sharp & Dohme LLC | 4 | $78 |
| Recor Medical Inc | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
Products named: Wegovy, FFRct, Kerendia, VERQUVO, Paradise Ultrasound Renal Denervation System, ENTRESTO, INJECTAFER, AMVUTTRA.
Industry payments across WI — which companies pay providers there.
